Cilastatin (Na)

Cilastatin (Na) is an aihibitor of enzyme dehydropeptidase I, found in the brush border of the renal tubules. Cilastatin (Na) is administered concomitantly with the antibiotic Imipenem to prevent its renal metabolism to microbiologically inactive and potentially nephrotoxic products. Cilastatin has no bacterial activity itself, and does not affect the antibacterial activity of imipenem.

Brands

STANEM PREPENEM TIENAM EURONEM

Adult Dose

Neonatal

Paedriatic

Characteristics

. It is of Synthetic origin and belongs to Amino Acid. . The Molecular Weight of Cilastatin (Na) is 380.40. It is weakly acidic drug.

Contraindications

Cilastatin (Na) is contraindicated in conditions like Hypersensitivity to any component of product.

Effects

The symptomatic adverse reactions produced by Cilastatin (Na) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Diarrhea, Fever, Rashes, Confusion, Allergic reactions, Nausea and vomiting, Hearing loss, Taste disturbanceX, Blood disorders, Tooth and tongue discoloration.

Indications

Cilastatin (Na) is primarily indicated in conditions like Small cell carcinoma.

Interactions

No data regarding the interactions of Cilastatin (Na) was found.

Interfrence

Risks

Drug should not be given to patients suffering from Kidney dysfunction.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Storage

Warnings

Neurotoxicity has been observed at very high dosage or in renal failure.

Back to List

Any information that appears on this website page is provided for the purpose of general information. This website has been compiled in good faith by HMIS.Online. However, no guarantee is made as to the completeness, validity or accuracy of the information it contains.